Is Gilead Sciences, Inc. overvalued?

Gilead Sciences, Inc. (GILD) looks overvalued — trading about 11% above its fair value.

Overvalued

Price

$135.87

Fair value

$121.32

Current P/E

20.0

Normal P/E

17.9

Market cap

$168.69B

Dividend yield

2.4%

Return on equity

-16.3%

Sector

Healthcare

Fair value compares GILD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks